JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Farhad Bakhtiary
Mirela Scherer
Omer Dzemali
Anton Moritz
Peter Kleine
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bakhtiary, F.
Right arrow Articles by Kleine, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bakhtiary, F.
Right arrow Articles by Kleine, P.
Related Collections
Right arrow Electrophysiology - arrhythmias

J Thorac Cardiovasc Surg 2008;136:1380-1381
© 2008 The American Association for Thoracic Surgery


Brief Communication

Electromagnetic interaction between an axial left ventricular assist device and an implantable cardioverter defibrillator

Farhad Bakhtiary, MD*, Panagiotis Therapidis, MD, Mirela Scherer, MD, Omer Dzemali, MD, Anton Moritz, MD, PhD, Peter Kleine, MD, PhD

Department of Thoracic and Cardiovascular Surgery of Johann-Wolfgang-Goethe University, Frankfurt am Main, Germany

Received for publication October 30, 2007; revisions received January 17, 2008; accepted for publication February 1, 2008.

* Address for reprints: Farhad Bakhtiary, MD, Department of Thoracic and Cardiovascular Surgery, Johann-Wolfgang-Goethe University, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany. (Email: farhad{at}bakhtiary.de).

As the prevalence of advanced heart failure continues to increase, implantation of the left ventricular assist device (LVAD) has become an excellent bridge to cardiac transplantation, recovery, or other future alternative therapies.1,2Go There is some evidence that LVAD therapy itself promotes new onset of ventricular arrhythmias in this patient group.1Go Implantation of an implantable cardioverter–defibrillator (ICD) is one treatment choice. There is little information concerning device–device interaction between the LVAD and ICD.2Go

This report describes the case of a patient with intraoperative interaction between the LVAD and a newly implanted left-sided ICD, which was ultimately solved by right-sided reimplantation.

Clinical Summary

A 54-year-old man was admitted to our institution in November 2006 with medically unresponsive end-stage heart failure resulting from dilated cardiomyopathy. He was in cardiogenic shock with a left ventricular ejection fraction of 15% and received extracorporeal membrane oxygenatation for 1 week. Implantation of a Thoratec HeartMate II LVAD (Thoratec Corporation, Pleasanton, Calif) with additional tricuspid valve annuloplasty was performed 10 days later. The LVAD inflow was positioned at the left ventricular apex, the outflow in the ascending aorta, and the device itself in the left upper part of the abdomen. His postoperative course was prolonged by respiratory insufficiency and intensive polyneuropathy. Finally, 100 days postoperatively, the patient was transferred to a neurologic and cardiac rehabilitation unit. After 6 weeks, the patient could be discharged from the rehabilitation center in good clinical condition.

Three months later, he was referred to our outpatient department for recurrent ventricular tachycardia. It was decided to implant a single-chamber ICD (Ela Ovatio VR; Sorin group, Saluggio, Italy). Transvenous lead implantation using a bipolar dual-coil lead with active fixation (Kentrox SL-S; Biotronik, Berlin, Germany) was uncomplicated (R-wave sensing, 8.5 mV, pacing threshold 0.75 mV, impedance 405{Omega}). The generator was implanted into a left subpectoral pocket. After lead connection and replacement of the same generator in the pocket, sufficient telemetry between the ICD and the defibrillator programmer could not be established despite use of multiple programmers and programming head positions. The telemetry head always received electromagnetic signals even when placed far away from the generator. Because of inability to interrogate or reprogram the ICD in this location, we decided to reimplant both the lead and the generator in the same setting on the right pre-pectoral position (Figure 1 ). After implantation, ICD telemetry was stable and successful and ICD function undisturbed with successful termination of provoked ventricular fibrillation.


Figure 1
View larger version (144K):
[in this window]
[in a new window]

 
Figure 1. Chest x-ray film showing an axial left ventricular assist device, a single-chamber implantable cardioverter–defibrillator, and a transvenous screw-in lead.

 
Conclusion

Some reports described the deleterious hemodynamic and clinical effects of ventricular arrhythmias in patients with LVADs, which may be caused by electrical instability owing to the underlying disease or mechanical disturbance by implantation of the apical inflow cannula.1Go As LVAD and ICD therapy is being used concomitantly more often in this patient group with end-stage heart failure, device malfunction resulting from interaction has to be avoided.2,3Go This report presents the case of a patient in whom intraoperative ICD interrogation was impossible owing to massive interference with the LVAD electromagnetic field. This problem could be solved by ICD displacement to the right pectoral side. The device–device interaction may be prevented by preoperative scanning of the thoracic wall using the ICD telemetry head, which should not display receipt of any electromechanical signals unless placed on top of the ICD generator. In cases of doubt, the generator should be implanted contralateral to the LVAD position, in the majority of cases at the right pectoral side rather than the left side.

References

  1. Ziv O, Dizon J, Thosani A, Naka Y, Magnano AR, Garan H. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol 2005;45:1428-1434.[Abstract/Free Full Text]
  2. Skinner JL, Bourge RC, Shepard RB, Epstein AE, Holman WL. Simultaneous use of an implanted defibrillator and ventricular assist device. Ann Thorac Surg 1997;64:1156-1158.[Abstract/Free Full Text]
  3. Matthews JC, Betley D, Morady F, Pelosi Jr. F. Adverse interaction between a left ventricular assist device and an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2007;18:1107-1108.[Medline]



This article has been cited by other articles:


Home page
Interact CardioVasc Thorac SurgHome page
H. Oswald, G. Klein, M. Struber, and A. Gardiwal
Implantable defibrillator with left ventricular assist device compatibility
Interact CardioVasc Thorac Surg, May 1, 2009; 8(5): 579 - 580.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Farhad Bakhtiary
Mirela Scherer
Omer Dzemali
Anton Moritz
Peter Kleine
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bakhtiary, F.
Right arrow Articles by Kleine, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bakhtiary, F.
Right arrow Articles by Kleine, P.
Related Collections
Right arrow Electrophysiology - arrhythmias


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS